| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |